New Zealand markets open in 34 minutes
  • NZX 50

    11,137.88
    -19.78 (-0.18%)
     
  • NZD/USD

    0.6363
    +0.0053 (+0.84%)
     
  • ALL ORDS

    7,350.60
    +24.40 (+0.33%)
     
  • OIL

    113.66
    -0.54 (-0.47%)
     
  • GOLD

    1,813.60
    -0.40 (-0.02%)
     

3 Can't-Miss Biotech Events Coming Up in 2022

·4-min read
3 Can't-Miss Biotech Events Coming Up in 2022

Here's why you'll want to keep both eyes open for upcoming announcements from Alnylam Pharmaceuticals (NASDAQ: ALNY), Intercept Pharmaceuticals (NASDAQ: ICPT), and Karuna Therapeutics (NASDAQ: KRTX). Shares of Alnylam recently slipped around 15% overnight in response to a surprising clinical-trial flop for a drug it isn't even developing. Recently, BridgeBio Pharma told investors that people with heart damage caused by transthyretin amyloidosis (ATTR) who received acoramidis failed to outperform the placebo group on the six-minute walking test.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting